We talk ORATOR, ORATOR 2 and the genesis of evidence in TORS!

Melvin Chua joins the deeply marginal crowd to talk EBV ctDNA, its clinical use, science, gardening and islands.

Chris Nutting, Professor of Radiotherapy and leader on many pivotal trials at the ICR joins us to talk through the past 25 years of radiotherapy advances and the data underpinning these. We talk about the future and Will has some technical difficulties so there is less nonsense than usual!

Dr Glenn Hanna, Director of the Center for Cancer Therapeutic Innovation (CCTI) at Dana Faber Cancer Insitute joins us for our 10th episode and it's a cracker; Glenn talks us through the finer points of ctDNA, MRD and what the future holds for this exciting space.

Professor Vin Paleri, Consultant Head and Neck Surgeon at The Royal Marsden Hospitals and Professor of Head and Neck Surgery at the Institute of Cancer Research talks us through salvage surgery data, patient selection and how to tame feral oncologists.

Paul Swieciki, Associate Professor from Michigan joins us for a deep dive into bispecifics. We talk future targets, current excitiement and Ben gets excited about merchandise and a potential grudge match with friend of the show hardman Ari Rosenberg. It's a belter!

David Sher, Medical Director of Radiation Oncology, Chief of Head and Neck Radiation Oncology Service at UT Southwestern joins us for a comprehensive discussion about radiotherapy and its interaction with the immune system. We cover SABR, perioperative trials and elective node irradiation; it's quite a journey!

Clare Schilling, Consultant oral and maxillofacial surgeon and honorary associate professor at the University College London Head and Neck Academic Centre (HNAC) joins us live from Birmingham, where Ben likes to holiday. We talk Weiss, D'Cruz, risk and the future. Clare invites Will and Ben to 'have a go at it' too -it's a real blast!